Additional Corticosteroids or Alternative Antibiotics for the Treatment of Macrolide-resistant Pneumonia

Overview

Journal Korean J Pediatr

Specialty Pediatrics

Date 2017 Oct 19

PMID 29042865

Citations 3

Authors

Eun-Ae Yang

Kyung-Yil Lee

Affiliations

Soon will be listed here.

Citing Articles

The effects of magainin 2-derived and rationally designed antimicrobial peptides on Mycoplasma pneumoniae.

Hayashi K, Misawa T, Goto C, Demizu Y, Hara-Kudo Y, Kikuchi Y PLoS One. 2022; 17(1):e0261893.

PMID: 35073323 PMC: 8786148. DOI: 10.1371/journal.pone.0261893.

Macrolide-Resistant and Macrolide-Sensitive Pneumonia in Children Treated Using Early Corticosteroids.

Han H, Park K, Yang E, Lee K J Clin Med. 2021; 10(6).

PMID: 33810090 PMC: 8004593. DOI: 10.3390/jcm10061309.

Low-Dose Corticosteroid Treatment in Children With Pneumonia: A Retrospective Cohort Study.

Zhang L, Wang L, Xu S, Li H, Chu C, Liu Q Front Pediatr. 2020; 8:566371.

PMID: 33330269 PMC: 7720903. DOI: 10.3389/fped.2020.566371.

References

Youn Y, Lee K . Mycoplasma pneumoniae pneumonia in children. Korean J Pediatr. 2012; 55(2):42-7. PMC: 3286761. DOI: 10.3345/kjp.2012.55.2.42. View

Lee K . Pediatric respiratory infections by Mycoplasma pneumoniae. Expert Rev Anti Infect Ther. 2008; 6(4):509-21. DOI: 10.1586/14787210.6.4.509. View

Hong K, Choi E, Lee H, Lee S, Cho E, Choi J . Macrolide resistance of Mycoplasma pneumoniae, South Korea, 2000-2011. Emerg Infect Dis. 2013; 19(8):1281-4. PMC: 3739509. DOI: 10.3201/eid1908.121455. View

Yang H, Song D, Shim J . Mechanism of resistance acquisition and treatment of macrolide-resistant pneumonia in children. Korean J Pediatr. 2017; 60(6):167-174. PMC: 5500384. DOI: 10.3345/kjp.2017.60.6.167. View

Kim E, Youn Y, Rhim J, Shin M, Kang J, Lee K . Epidemiological comparison of three Mycoplasma pneumoniae pneumonia epidemics in a single hospital over 10 years. Korean J Pediatr. 2015; 58(5):172-7. PMC: 4481037. DOI: 10.3345/kjp.2015.58.5.172. View

Rhim J, Lee K, Youn Y, Kang J, Kim J . Epidemiological and clinical characteristics of childhood pandemic 2009 H1N1 virus infection: an observational cohort study. BMC Infect Dis. 2011; 11:225. PMC: 3176209. DOI: 10.1186/1471-2334-11-225. View

Hegde S, Hegde S, Spergser J, Brunthaler R, Rosengarten R, Chopra-Dewasthaly R . In vitro and in vivo cell invasion and systemic spreading of Mycoplasma agalactiae in the sheep infection model. Int J Med Microbiol. 2014; 304(8):1024-31. PMC: 4282308. DOI: 10.1016/j.ijmm.2014.07.011. View

Lee K, Lee H, Hong J, Lee M, Lee J, Burgner D . Role of prednisolone treatment in severe Mycoplasma pneumoniae pneumonia in children. Pediatr Pulmonol. 2006; 41(3):263-8. DOI: 10.1002/ppul.20374. View

Mills G, Oehley M, Arrol B . Effectiveness of beta lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysis. BMJ. 2005; 330(7489):456. PMC: 549658. DOI: 10.1136/bmj.38334.591586.82. View

10.

Lee K . A common immunopathogenesis mechanism for infectious diseases: the protein-homeostasis-system hypothesis. Infect Chemother. 2015; 47(1):12-26. PMC: 4384454. DOI: 10.3947/ic.2015.47.1.12. View

11.

Denny F, CLYDE Jr W, Glezen W . Mycoplasma pneumoniae disease: clinical spectrum, pathophysiology, epidemiology, and control. J Infect Dis. 1971; 123(1):74-92. DOI: 10.1093/infdis/123.1.74. View

12.

You S, Jwa H, Yang E, Kil H, Lee J . Effects of Methylprednisolone Pulse Therapy on Refractory Mycoplasma pneumoniae Pneumonia in Children. Allergy Asthma Immunol Res. 2014; 6(1):22-6. PMC: 3881395. DOI: 10.4168/aair.2014.6.1.22. View

13.

Youn Y, Lee K, Hwang J, Rhim J, Kang J, Lee J . Difference of clinical features in childhood Mycoplasma pneumoniae pneumonia. BMC Pediatr. 2010; 10:48. PMC: 2910686. DOI: 10.1186/1471-2431-10-48. View

14.

Hirao S, Wada H, Nakagaki K, Saraya T, Kurai D, Mikura S . Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone. FEMS Immunol Med Microbiol. 2011; 62(2):182-9. DOI: 10.1111/j.1574-695X.2011.00799.x. View

15.

Torres A, Sibila O, Ferrer M, Polverino E, Menendez R, Mensa J . Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA. 2015; 313(7):677-86. DOI: 10.1001/jama.2015.88. View

16.

Gardiner S, Gavranich J, Chang A . Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children. Cochrane Database Syst Rev. 2015; 1:CD004875. PMC: 10585423. DOI: 10.1002/14651858.CD004875.pub5. View

17.

Becker A, Kannan T, Taylor A, Pakhomova O, Zhang Y, Somarajan S . Structure of CARDS toxin, a unique ADP-ribosylating and vacuolating cytotoxin from Mycoplasma pneumoniae. Proc Natl Acad Sci U S A. 2015; 112(16):5165-70. PMC: 4413325. DOI: 10.1073/pnas.1420308112. View

18.

Takei T, Morozumi M, Ozaki H, Fujita H, Ubukata K, Kobayashi I . Clinical features of Mycoplasma pneumoniae infections in the 2010 epidemic season: report of two cases with unusual presentations. Pediatr Neonatol. 2013; 54(6):402-5. DOI: 10.1016/j.pedneo.2012.11.016. View

19.

Lee K . Pneumonia, Acute Respiratory Distress Syndrome, and Early Immune-Modulator Therapy. Int J Mol Sci. 2017; 18(2). PMC: 5343923. DOI: 10.3390/ijms18020388. View

20.

Youn Y, Lee S, Rhim J, Shin M, Kang J, Lee K . Early Additional Immune-Modulators for Mycoplasma pneumoniae Pneumonia in Children: An Observation Study. Infect Chemother. 2015; 46(4):239-47. PMC: 4285006. DOI: 10.3947/ic.2014.46.4.239. View